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Background. Brain natriuretic peptide and its inactive fragment N-terminal pro-BNP (N-BNP) are reliable markers of ventricular
dysfunction in adults and children. We analyzed the impact of nutritional state on N-BNP levels in infants with failure to thrive
(FTT) and in infants with severe heart failure (HF). The purpose of this study was to compare N-BNP levels in infants with FTT
with infants with severe HF and healthy controls. Methods. In a retrospective cohort study, we compared N-BNP levels from all
consecutive infants with FTT and bodyweight below the tenth percentile (caloric deprivation (CD) group) to infants with severe
HF. Reference values from infants between 2 and 12 month were taken from the literature and healthy infants. Results. Our results
show that infants with FTT (n = 15) had signiﬁcantly (P<. 001) elevated N-BNP values compared with the healthy infants
(n = 23), 530 (119–3150)pg/mL versus 115 (15–1121)pg/mL. N-BNP values in this CD group are comparable to the median
value of infants with severe HF (n = 12) 673 (408–11310)pg/mL. There is no statistical signiﬁcant diﬀerence in age. Conclusion.
Nutritional state has an important impact on N-BNP levels in infants with FTT. We could show comparable levels of N-BNP in
infants with FTT and infants with severe HF.
1.Introduction
Approximately 10% of children seen in primary care develop
signs of failure to thrive (FTT). The clinical evaluation
includes a thorough history and physical examination.
Children who do not respond to treatment for inadequate
caloric intake or have a suspected “organic” cause get
further laboratory diagnosis to identify the 1% of cases with
FTT that result from diagnosable disease. In addition to
inadequate caloric intake and caloric absorption, excessive
caloric consumption due to hyperthyroidism, malignancy,
and chronic disease such as severe heart failure (HF) must
be considered.
Elevated N-Terminal pro brain natriuretic peptide (N-
BNP) levels were found in children with severe HF due to
congenital heart disease or dilated cardiomyopathy [1, 2].
From2005to2008weincludedN-BNPmeasurementsinour
laboratoryprogramforinfantswithFTTinanattempttouse
a laboratory test to identify infants who suﬀer from severe
HF. Surprisingly we found signiﬁcantly elevated N-BNP in
infants with FTT without any evidence for cardiac disease.
The purpose of this study was to compare N-BNP levels
in infants with FTT with infants with severe HF and healthy
controls from recently published N-BNP values.
2. Methods
The study design is a retrospective cohort study. Consecutive
infants who were admitted to our hospital with FTT and
bodyweight below the tenth percentile from 2005 to 2008
were included. Those infants with an organic cause of FTT
like short bowel syndrome or endocrinologic disease were
excluded. The remaining infants of the caloric deprivation
(CD) group suﬀer from failure to thrive due to inadequate
caloric intake and inappropriate type or volume of feeding.
The infants with severe HF due to congenital heart disease
were taken together in the “heart failure” group. History2 International Journal of Pediatrics
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Figure 1: N-BNP values are illustrated as box and whiskers. The
horizontal lines in the box plots reﬂect median value; the boxes
reﬂect the 25th and 75th perecentile and the whiskers represent
the maximum and minimum values: reference values from the
literature[3],23healthyinfantsbetween2and12month,15infants
withFTT,and11infantswithsevereHF.N-BNPvaluesareony-axis
(log-scale). In comparison to the healthy infants the P-value of the
CD group is high signiﬁcant (P = .0002) and the P-value of the HF
group in comparison to the CD group is not signiﬁcant (P = .12).
included the social standard of living, feeding behaviours,
and family disorders. A whole body examination was
performed. All infants received an echocardiography from
a well-versed paediatric cardiologist. Normal N-BNP values
shown in Figure 1 were taken from the literature [3]. For
statistical analysis shown in Table 2, we received the original
data for healthy infants from Norozi et al. [4]a n dK o c he ta l .
[5]. These data were recently published in peer-reviewed
journals.
Peripheral venous blood samples were obtained from
all participants, after a rest for at least 15 minutes. The
subjects were in the supine position during blood sampling,
which was typically done between 8:30 A.M. and 11:00
A.M. The blood samples were immediately placed on ice
and subsequently centrifuged at 5000rpm for 10 minutes.
In all children N-BNP was determined using immunoassay
(Elecsys 2010, Roche, Germany).
2.1. Exclusion Criteria. We excluded all infants with
“organic” cause for FTT like short bowel syndrome or
endocrinologic disease. Each patient had normal C-reactive
protein values and therefore we could exclude signiﬁcant
inﬂammation.
N-BNP serum concentrations are markedly elevated in
the ﬁrst days of life in healthy neonates, probably due to
circulatory changes in the perinatal period. All patients up
to 31 days of life were excluded in both patient groups.
2.2. Statistical Analysis. Continuous variables were reported
asmedianrangeandanalyzedusingnonparametrictests.For
all parameters, a value of P<. 05 was considered statistically
signiﬁcant.TheMann-Whitneytestwasusedforcomparison
of N-BNP values of our patients and the original data from
healthy infants published by Norozi et al. [4]a n dK o c he ta l .
[5]. The data analyses were performed using Excel 2000
(Microsoft, USA) and Prism (GraphPad software Inc., USA).
The study was approved by the local ethic committee.
3. Results
Demographic and height and weight characteristics for the
three study groups are summarized in Table 1. 26 patients
were included in our study, the CD group contained 15
patients, and the HF group contained 11 patients. 5 patients
were excluded due to organic causes. As shown in Table 1
there is no signiﬁcant statistical diﬀerence in age, body-
weight, body length, gestational age, and head circumference
in the CD group and the HF group. Gestational age and
birth weight were within normal limits. The CD group had
a signiﬁcantly lower postnatal weight gain 73 (0–147)g/week
athomemostlycausedbyinadequatebreastfeedingathome,
compared with the weight gain during hospital stay 225
(100–500)g/week.Furtherlaboratoryinvestigationsshowno
signiﬁcant diﬀerence for haemoglobin, white blood cells,
ALT, and creatinine values in infants with HF compared to
the infants with FTT. All these data were within the normal
range.
The HF group included 7 infants prior to cardiac surgery
(ventricular septal defects or atrioventricular septal defects).
FourinfantssuﬀeredfromsevereHFmorethan2weeksafter
cardiac surgery (transposition of the great arteries, single
ventricle). Seven infants with severe HF received a medi-
cal therapy with digoxin, diuretics, angiotensin converting
enzyme inhibitors, and/or beta-blocker.
The laboratory investigations are shown in Table 2.F o r
statistical analysis we compared the CD group with healthy
infants and with the HF group. Our results show that infants
with FTT had signiﬁcantly elevated N-BNP values compared
with the healthy infants 115 (15–1121)pg/mL versus 530
(119–3150)pg/mL, P<. 001. N-BNP values in the CD group
are not signiﬁcantly diﬀerent from values of infants with
severe HF 673pg/mL, (408 – 35000)pg/mL.
AsshowninFigure 1N-BNPofourhealthyinfantsgroup
is in accordance with the reference values from the literature
[3]. The median is nearly 4-fold higher in infants with FTT.
4. Discussion
Brain natriuretic peptide is secreted mainly by cardiac
myocytes of the ventricles and to a lesser degree of the atria.
Natriuretic peptides are released from the heart in response
t op r e s s u r ea n dv o l u m eo v e rl oa d[ 6]. However, several recent
studies demonstrate an inverse relationship between body
mass index and N-BNP levels were completed in adults
with and without severe HF [7]. In this study we present
signiﬁcant N-BNP elevations in a group of 15 infants with
CD. These infants only suﬀer from an inadequate caloric
intake without any evidence for severe HF, congenital heart
disease, and liver or kidney disease. HF and congenital heart
disease in the CD group were excluded by echocardiography.
There was no evidence of diastolic dysfunction on theInternational Journal of Pediatrics 3
Table 1: Growth characteristics.
Healthy infants Caloric deprivation Heart failure
N 23 15 11
Age (days) 166 (35–372) 160 (15–347) 90 (31–344)
Bodyweight < 3% 13 4
Bodyweight 3%–10% 2 2
Bodyweight > 10% 0 5
Bodyweight (g) 7600 (4800–10000) 4820 (2660–6700) 4350 (2755–8370)
Body length (cm) 69 (58–79) 62 (50–70) 59 (49–75)
Head circumference (cm) 40 (34–44.5) 38 (31–48)
Birth weight (g) 3100 (2130–3580) 3180 (1910–3670)
Gestational Age (w) 39 (36–41) 39 (34–42)
Values are given in median range, There is no signiﬁcant statistical diﬀerence between “Caloric Deprivation” and “Heart Failure”.
Table 2: Laboratory results.
Healthy infants Caloric deprivation Heart failure
N 23 15 11
NT-Pro-BNP (pg/mL) 115 (15–1121) 530 (119 −−3150)
∗∗ 673 (408–35000)
Age (days) 166 (35–372) 160 (15–347) 90 (31–344)
Normal Range
HB (g/100mL) 11–15 11.3 (9.5–16.8) 12.1 (9.4–17.8)
WBC (1/mL) 5500–17500 10800 (6400–14200) 10000 (4500–22000)
CRP (mg/L) <8 1.8 (0.00–2.36) 1.1 (0.00–2.12)
Creatinine (mg/dL) 0.04–0.68 0.23 (0.20–0.38) 0.36 (0.20–0.86)
Urea (mg/dL) 5.7–20.1 19 (9–28) 23.5 (10–70)
ALT (U/L) 0–45 30 (14–303) 24 (14–65)
Values are given in median range; Statistical Analysis using Mann Whitney Test between group “Healthy Infants” versus “Caloric Deprivation” and “Caloric
Deprivation” versus “Heart Failure”. ∗∗P-value = .0002 (CD versus healthy infants).
echocardiograms, indicated by normal mitral valve inﬂow
proﬁles. In our study the age of the remaining infants was
in good accordance with the reference group of the literature
[3]. The median N-BNP level of our infants with FTT 530
(119–3150)pg/mL) is comparable to children with Ross class
III HF (744pg/mL) [1]. Our heart failure group included
only infants with severe HF with a very high N-BNP level
of 408–35000pg/mL. Interestingly, 58% of these infants with
severe HF also suﬀer from FTT. These data are in good
accordance with data from a pilot study regarding N-BNP in
patients with HF due to ventricular septal defects showing
that the perioperative change in N-BNP was most closely
correlated with improved weight gain [2]. Also it is well
known from adults with severe HF that cachectic patients
have the highest N-BNP levels [8].
Although the reason for the relationship between body
mass index and N-BNP is unknown, the increased con-
centration of the natriuretic peptide receptor-C clearance
receptor on adipocyte cells has led some to postulate
that increased clearance is the reason for lower N-BNP
levels in obese patients [9]. However, evidence against
this hypothesis comes from Das et al. [10], who found
that N-BNP was correlated with greater lean mass but
not greater fat mass. Cachexia in severe HF is associated
with an increase in adiponectin concentration [11]. This
may represent preservation of the physiological response to
change in body fat but might also suggest that adiponectin
plays a role in the pathogenesis of cachexia. The correlation
between BNP and adiponectin also raises the possibility
that the former might increase the secretion of the latter.
In an experimental setting Tsukamoto could show that
administration of BNP over 14 days in rats increased
the plasma adiponectin concentration and concluded that
BNP enhances adiponectin production in adipocytes, and
BNP is a potential regulator of adiponectin production
[12]. Ohara et al. found that the plasma adiponectin level
increased along with an increase of plasma BNP in healthy
subjects independently of other confounding factors and
they concluded that adiponectin reﬂects cardiac function
[13].
Our data are important for the interpretation of N-BNP
levels in childhood. For example, the authors who published
the reference values of N-BNP serum concentrations in
healthy neonates and children did not give any information
about the bodyweight of their study group [3]. This may
be the reason for their high range of reference values (5–
1121pg/mL) in so-called healthy infants between 2 and 12
months.4 International Journal of Pediatrics
We urgently need reference values from infants with a
well-documented normal nutritional state. Further studies
may delineate whether measuring N-BNP levels are useful
for the initial evaluation or ongoing management of patients
with FTT due to either inadequate caloric intake or severe
HF.
The pathophysiological consequence of elevated natri-
uretic peptides in children with FTT with regard to volume
regulation, blood pressure, and cardiovascular prognosis
remains speculative. Our observation reveals new horizons
for the explanation of well-known cardiovascular risk factors
like the enhanced cardiovascular mortality in patients with
low birth weight or FTT during infancy (Barker hypothesis)
[14]. The link between low birth weight and FTT in infancy,
catch-up growth in early childhood [15], and the higher
risk of death from coronary heart disease in adults is
important but yet not well understood. Longitudinal N-BNP
measurements in these patient groups may help for a better
pathophysiological understanding of Barkers hypothesis and
risk stratiﬁcation in infants with low birth weight and FFT.
4.1.StudyLimitation. Astatisticalproblemisbaseduponthe
high range of N-BNP values in healthy infants especially in
the ﬁrst four weeks of life. These patients had to be excluded.
Due to the nature of our retrospective study we were not able
to measure adiponectin in our patients, which could be very
helpful for interpretation of enhanced N-BNP, especially if
there were a correlation between the level of adiponectin and
N-BNP. Additional limitations of the study include the fact
that there are a relatively small number of patients, and that
data were obtained at a single time point without additional
follow-up values.
Abbreviations
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